HELIX BIOMEDIX INC
Bothell, WA · CIK 0000831749 · Biotech · Private
Therapeutic molecules and drugs targeting Xeroderma Pigmentosum
helixbiomedix.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $17M
- 6 Form D · Jul 2019
- 87 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 20
- 6 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,900,000 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $599,838 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $5,978,276 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $5,625,120 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1500 | Atavistik Bio | — | — |
| 1501 | Ring Therapeutics | — | — |
| 1502 | VIVA VIRAL VACCINES, INC. | — | — |
| 1503 | HELIX BIOMEDIX INC | — | $17M |
| 1504 | VIVOSCRIPT, INC. | — | — |
| 1505 | WELLSIM BIOMEDICAL TECHNOLOGIES, INC. | — | — |
| 1506 | VLP BIOTECH, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- R. BeattyDirector · Executive Officer
- R. Stephen BeattyDirector · Executive Officer
- Robin CarmichaelDirector · Executive Officer
- Randall CaudillDirector
- John CliffordDirector
- Richard CohenDirector
- Timothy FallaExecutive Officer
- John FiddesDirector
- L. JonesDirector
- Lawrence JonesDirector
- Jeffrey MillerDirector
- David O'ConnorDirector
- Barry SeidmanDirector
- Daniel WildsDirector
Patents
- Peptide Fragments For Inducing Synthesis Of Extracellular Matrix Proteinsgranted
- Tetrapeptides Derived from Human C-X-C Chemokines Useful for Treatment of Various Skin Conditionsgranted
- Short Bio-Active Peptides for Promoting Wound Healingapplication
- Short Bio-active Peptides For Promoting Wound Healinggranted
- Peptide Fragments For Inducing Synthesis Of Extracellular Matrix Proteinsgranted
- Short Antimicrobial Lipopeptidesgranted
- Peptide Fragments For Inducing Synthesis Of Extracellular Matrix Proteinsgranted
- Short Antimicrobial Lipopeptidesapplication
- Peptide Protection Against Ultraviolet Light Toxicityapplication
- Protective Skin Care Peptidesapplication
- Short Bio-active Peptides For Cellular And Immunological Modulationapplication
- Peptide Fragments For Inducing Synthesis Of Extracellular Matrix Proteinsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.